We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$907M
AUM Growth
+$46.9M
Cap. Flow
+$58.5M
Cap. Flow %
6.45%
Top 10 Hldgs %
29.15%
Holding
221
New
13
Increased
80
Reduced
54
Closed
8

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$15.8M
2
MGA icon
Magna International
MGA
+$7.42M
3
LYB icon
LyondellBasell Industries
LYB
+$4.44M
4
LRCX icon
Lam Research
LRCX
+$3.67M
5
MTCH icon
Match Group
MTCH
+$3.23M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.02M
2
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.4M
3
TGT icon
Target
TGT
+$342K
4
HD icon
Home Depot
HD
+$330K
5
MSFT icon
Microsoft
MSFT
+$310K

Sector Composition

Rank Sector Weight
1 Technology 28.95%
2 Healthcare 18.07%
3 Financials 10.32%
4 Industrials 8.97%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMI icon
201
Cummins
CMI
$87.9B
$215K 0.02%
958
– –
SPGI icon
202
S&P Global
SPGI
$121B
$212K 0.02%
500
– –
VHT icon
203
Vanguard Health Care ETF
VHT
$19B
$212K 0.02%
856
-300
-26% -$77K
AYI icon
204
Acuity Brands
AYI
$10.6B
$209K 0.02%
1,205
– –
BXMX
205
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$209K 0.02%
14,655
-347
-2% -$5.09K
MMSI icon
206
Merit Medical Systems
MMSI
$5.37B
$208K 0.02%
+2,900
New +$197K
OEF icon
207
iShares S&P 100 ETF
OEF
$20.5B
$207K 0.02%
1,050
– –
MLAB icon
208
Mesa Laboratories
MLAB
$573M
$204K 0.02%
+675
New +$192K
TDOC icon
209
Teladoc Health
TDOC
$1.29B
$204K 0.02%
1,605
– –
IYW icon
210
iShares US Technology ETF
IYW
$25.4B
$203K 0.02%
+2,000
New +$209K
UVE icon
211
Universal Insurance Holdings
UVE
$1.21B
$196K 0.02%
15,000
– –
DRIO icon
212
DarioHealth
DRIO
$73.7M
$136K 0.02%
500
– –
PVL
213
Permianville Royalty Trust
PVL
$58.1M
$23K ﹤0.01%
12,000
– –
AXON
214
Axon Enterprise
AXON
$47.8B
– –
-1,140
Closed -$202K
MRCY icon
215
Mercury Systems
MRCY
$6.5B
– –
-3,190
Closed -$211K
NEOG icon
216
Neogen
NEOG
$2.5B
– –
-4,450
Closed -$205K
OGN icon
217
Organon & Co
OGN
$3.58B
– –
-7,226
Closed -$219K
V icon
218
Visa
V
$671B
– –
-872
Closed -$204K
VTRS icon
219
Viatris
VTRS
$18.9B
– –
-10,599
Closed -$151K
MNDT
220
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-69,200
Closed -$1.4M
GAB.RT
221
DELISTED
The Gabelli Equity Trust Inc. Rights (expiring July 14, 2021)
GAB.RT
– –
-208,340
Closed -$24K
5 6 7 8
9

Similar funds

KCM
Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.52B AUM
ACL
Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return
ARAM
Ardmore Road Asset Management New York $1.52B AUM 56.21% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return

Marco Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Marco Investment Management held 221 positions worth $907M, up 5.5% from $861M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Marco Investment Management deployed $58.5M of net new capital in Q3 2021, opening 13 new positions and adding to 80 existing holdings. Its largest new stake was Cigna: 72,551 shares worth $14.5M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.02M trimmed.

  • Marco Investment Management's largest Q3 2021 buy was Cigna: 72,551 shares worth $14.5M.
  • Marco Investment Management added most to LyondellBasell Industries in Q3 2021, an estimated $4.44M increase.
  • Marco Investment Management's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $2.02M.
  • Marco Investment Management fully exited Mandiant, Inc. Common Stock in Q3 2021, selling an estimated $1.4M.
  • Marco Investment Management's ten largest holdings make up 29% of its $907M portfolio in Q3 2021.
  • Marco Investment Management opened 13 new positions and closed 8 in Q3 2021.
  • Marco Investment Management's portfolio value rose 5.5% quarter-over-quarter to $907M.

Based on Marco Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.